Table 4

Ultrasound of liver at 6 months follow up post-implementation of measures to achieve glycemic control in patients with hyperechogenic liver and/or hepatomegaly
Hepatomegaly group At baseline At 6 months follow up
Patient Insulin (U/kg/d) HbA1C% Insulin (U/kg/d) HbA1C% U/S liver
1 0.8 12 0.70 8.7 Normal
2* 0.5 10 0.75 11 Mild hepatomegaly
3 0.86 8.9 0.7 7.4 Normal
4* 0.59 7.4 0.5 8 Mild hepatomegaly
5 0.66 10.8 0.75 7.2 Normal
6 1 12.5 0.8 7.5 Normal
7* 0.62 8.1 0.7 8.8 Mild hepatomegaly
8* 0.88 8.9 0.8 9.5 Mild hepatomegaly
9 0.86 7 0.65 6.5 Normal
10 1.12 8.5 0.7 6.8 Normal

Hyperechogenic liver group

Patient

1 0.73 11.6 0.85 8.8 Normal
2 0.48 13.6 0.7 8.2 Normal
3‡ 0.69 10.6 0.8 7.5 Normal
4* 0.5 13 0.75 12.4 hyperechogenic liver
5‡ 0.87 12.3 0.85 7.4 Normal
6* 0.6 14.5 0.9 13 hyperechogenic liver
7 0.55 12.7 0.75 9 Normal
8 0.64 9.1 0.70 8.2 Normal
9‡ ¶ 0.46 14.1 0.75 10.5 hyperechogenic liver
10‡ ¶ 0.75 13 0.90 9.8 hyperechogenic liver
11 0.72 13 0.80 8.8 Normal
12* 0.46 8.2 0.65 10.5 hyperechogenic liver

‡: patient with celiac disease; *: Non-adherent to diabetic diet; ¶: Non-adherent to gluten free diet.

Al-Hussaini et al.

Al-Hussaini et al. BMC Pediatrics 2012 12:160   doi:10.1186/1471-2431-12-160

Open Data